000 01345 a2200397 4500
005 20250515151849.0
264 0 _c20090302
008 200903s 0 0 eng d
022 _a1464-3405
024 7 _a10.1016/j.bmcl.2008.11.052
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWard, Simon E
245 0 0 _aStudies on a series of potent, orally bioavailable, 5-HT(1) receptor ligands--part II.
_h[electronic resource]
260 _bBioorganic & medicinal chemistry letters
_cJan 2009
300 _a428-32 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdministration, Oral
650 0 4 _aAnimals
650 0 4 _aBiological Availability
650 0 4 _aLigands
650 0 4 _aQuinolines
_xadministration & dosage
650 0 4 _aRats
650 0 4 _aReceptors, Serotonin, 5-HT1
_xdrug effects
650 0 4 _aStructure-Activity Relationship
700 1 _aEddershaw, Peter
700 1 _aFlynn, Sean T
700 1 _aGordon, Laurie
700 1 _aLovell, Peter J
700 1 _aMoore, Susan H
700 1 _aScott, Claire M
700 1 _aSmith, Paul W
700 1 _aThewlis, Kevin M
700 1 _aWyman, Paul A
773 0 _tBioorganic & medicinal chemistry letters
_gvol. 19
_gno. 2
_gp. 428-32
856 4 0 _uhttps://doi.org/10.1016/j.bmcl.2008.11.052
_zAvailable from publisher's website
999 _c18523943
_d18523943